Adagene Inc. (FRA:978)
Germany flag Germany · Delayed Price · Currency is EUR
3.340
+0.060 (1.83%)
Last updated: Aug 26, 2026, 3:25 PM CET

Adagene Revenue

Adagene had revenue of $1.62M USD in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to $9.29M, up 8,902.38% year-over-year. In the year 2025, Adagene had annual revenue of $7.67M with 7,332.76% growth.

Revenue (ttm)
$9.29M
Revenue Growth
+8,902.38%
P/S Ratio
27.28
Revenue / Employee
$72.58K
Employees
128
Market Cap
221.87M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.67M7.57M7,332.76%
Dec 31, 2024103.20K-18.01M-99.43%
Dec 31, 202318.11M8.82M94.90%
Dec 31, 20229.29M-882.53K-8.67%
Dec 31, 202110.18M9.47M1,351.71%
Dec 31, 2020700.91K220.91K46.02%
Dec 31, 2019480.00K-1.03M-68.24%
Dec 31, 20181.51M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Biotest GmbH & Co. KGaA648.90M
Novogenia AG54.30M
Paion AG14.81M
MagForce AG1.08M
Biomark Diagnostics37.15K
co.don AG22.00K
bioXXmed AG16.73K
2invest AG-1.64M
Revenue Rankings